Eckert & Ziegler SE (BIT:1EUZ)

Market Cap	926.09M -16.6%
Revenue (ttm)	304.47M +9.6%
Net Income	39.75M +35.3%
EPS	0.63 +34.6%
Shares Out	n/a
PE Ratio	23.30
Forward PE	17.50
Dividend	0.17 (1.11%)
Ex-Dividend Date	Jun 19, 2025

Volume	n/a
Average Volume	50
Open	n/a
Previous Close	15.00
Day's Range	n/a
52-Week Range	14.26 - 22.83
Beta	n/a
RSI	47.26
Earnings Date	Mar 26, 2026

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-co...

• Industry: Industrial Inorganic Chemicals
• Founded: 1992
• Employees: 1,112
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1EUZ

Financial Performance

In 2024, Eckert & Ziegler SE's revenue was 295.85 million, an increase of 20.22% compared to the previous year's 246.09 million. Earnings were 33.28 million, an increase of 26.52%.